Avalon Globocare is a real estate services business based in the US. Avalon Globocare shares (AVCO) are listed on the NASDAQ and all prices are listed in US Dollars. Avalon Globocare employs 5 staff and has a trailing 12-month revenue of around $1.4 million.
Our top picks for where to buy Avalon Globocare stock
How to buy Avalon Globocare stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – AVCO. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Avalon Globocare stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Avalon Globocare stock price (NASDAQ: AVCO)
Use our graph to track the performance of AVCO stocks over time.Avalon Globocare shares at a glance
Latest market close | $0.43 |
---|---|
52-week range | $0.00 - $0.00 |
50-day moving average | $0.50 |
200-day moving average | $0.58 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.10 |
Is it a good time to buy Avalon Globocare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avalon Globocare price performance over time
Historical closes compared with the close of $0.4315 from 2022-12-14
1 week (2024-08-27) | N/A |
---|---|
1 month (2024-08-03) | N/A |
3 months (2024-06-03) | N/A |
6 months (2024-03-03) | N/A |
1 year (2023-09-03) | N/A |
---|---|
2 years (2022-09-07) | -14.21% |
3 years (2021-09-07) | 0.9 |
5 years (2019-09-06) | 1.97 |
Avalon Globocare financials
Revenue TTM | $1.4 million |
---|---|
Gross profit TTM | $354,055 |
Return on assets TTM | -47.81% |
Return on equity TTM | -497.06% |
Profit margin | 0% |
Book value | $0.00 |
Market Capitalization | $52.2 million |
TTM: trailing 12 months
Avalon Globocare share dividends
We're not expecting Avalon Globocare to pay a dividend over the next 12 months.
Have Avalon Globocare's shares ever split?
Avalon Globocare's shares were split on a 1:10 basis on 4 January 2023. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avalon Globocare shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Avalon Globocare shares which in turn could have impacted Avalon Globocare's share price.
Avalon Globocare share price volatility
Over the last 12 months, Avalon Globocare's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avalon Globocare's is 0.8063. This would suggest that Avalon Globocare's shares are less volatile than average (for this exchange).
Avalon Globocare overview
Avalon GloboCare Corp. , together with its subsidiaries, owns and operates commercial real estate properties in the United States and the People's Republic of China. The company offers medical related consulting services, including research studies, executive education, daily online executive briefings, tailored expert advisory services, and consulting and management services in the areas of immunotherapy and second opinion/referral services. Its leading candidates are AVA-001, an anti-CD19 CAR-T, which has completed first-in-human clinical trial for relapsed/refractory (R/R) B-cell lymphoblastic leukemia; and AVA-011 that has completed pre-clinical laboratory studies and undergoing IND-enabling process development stage to generate cGMP-grade AVA-011 CAR-T cells. It is also developing RNA-based FASH-CARTM cell therapy platform. In addition, the company develops avalon clinical-grade tissue-specific exosome (ACTEX); offers therapeutic and diagnostic targets utilizing QTY-code protein design technology with Massachusetts Institute of Technology (MIT), including using the QTY code protein design technology for development of a hemofiltration device to treat Cytokine Storm; and provides co-development of next generation, transposon-based, multi-target CAR-T, CAR-NK, and other immune effector cell therapeutic modalities with Arbele Limited. Further, it has strategic partnership with the University of Natural Resources and Life Sciences in Vienna and Austria to develop an S-layer vaccine that could be administered by an intranasal or oral route against SARS-CoV-2 and coronavirus that causes COVID-19 disease; and develops Avalon Cell and Avalon Rehab, as well as promotes standardization related to exosome industry.
Frequently asked questions
nullWhat percentage of Avalon Globocare is owned by insiders or institutions?
Currently 66.402% of Avalon Globocare shares are held by insiders and 0.945% by institutions. How many people work for Avalon Globocare?
Latest data suggests 5 work at Avalon Globocare. When does the fiscal year end for Avalon Globocare?
Avalon Globocare's fiscal year ends in December. Where is Avalon Globocare based?
Avalon Globocare's address is: 4400 Route 9 South, Freehold, NJ, United States, 07728 What is Avalon Globocare's ISIN number?
Avalon Globocare's international securities identification number is: US05344R1041 What is Avalon Globocare's CUSIP number?
Avalon Globocare's Committee on Uniform Securities Identification Procedures number is: 05344R104
More guides on Finder
-
Options profit calculator
Use this calculator to quickly see potential outcomes of your options trades.
-
Best options trading platforms of 2024
SoFi, Robinhood, Tastytrade, Webull, Interactive Brokers, E*TRADE, eToro and others top our list for the best options trading platforms.
-
What is a covered call?
A covered call is an options trading strategy that allows you to generate income from stocks you already own.
-
GSD Capital review 2024
A look at GSD Capital’s highlights, limitations, fees and investment strategies.
-
Today’s best brokerage account bonuses [Signup and transfer promos]
Explore the best bonuses for opening a new brokerage account.
-
10 E*TRADE competitors worth your time
Looking for a discount broker like E*TRADE that offers something different? Here are some of the top alternatives to consider.
-
Charles Schwab vs. Fidelity
Charles Schwab and Fidelity are two powerhouse trading platforms for beginner and advanced investors.
-
Interactive Brokers review 2024: Tailored trading and investing
Interactive Brokers has advanced charting tools but a high net requirement to qualify.
-
Top 15 tech stocks to invest in for 2024
Discover the top tech stocks poised to lead innovation and offer substantial growth opportunities.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
Ask a question